ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00834665
Recruitment Status : Active, not recruiting
First Posted : February 3, 2009
Last Update Posted : August 19, 2016
Sponsor:
Collaborator:
University of Maryland
Information provided by (Responsible Party):
University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016